Exaggerated platelet reactivity in major depression

American Journal of Psychiatry

Volumn 153, Issue 10, 1996, Pages 1313-1317

  Musselman, Dominique L ^b   Tomer, Aaron ^b   Manatunga, Amita K ^b   Knight, Bettina T ^b   Porter, Maryfrances R ^b   Kasey, Suha ^b   Marzec, Ulla ^b   Harker, Laurence A ^b   Nemeroff, Charles B ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 10A; FIBRINOGEN RECEPTOR; LIPOCORTIN 5; MONOCLONAL ANTIBODY; PADGEM PROTEIN;

ADULT; ARTICLE; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; FLOW CYTOMETRY; HEART INFARCTION; HUMAN; IMMUNOFLUORESCENCE; ISCHEMIC HEART DISEASE; MALE; PRIORITY JOURNAL; RISK FACTOR; STANDING; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE RELEASE REACTION;

EID: 0029786527     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.153.10.1313     Document Type: Article

References (26)

1. Aromaa A, Raitasalo R, Reunanen A, Impivaara O, Heliovaara M, Kneckt P, Lehtinen V, Joukamaa M, Maatela J: Depression and cardiovascular diseases. Acta Psychiatr Scand 1994; 377: 77-82
2. Carney RM, Rich MW, teVelde A, Saini J, Clark K, Jaffe AS: Major depressive disorder in coronary artery disease. Am J Cardiol 1987; 60:1273-1275
3. Carney RM, Rich MW, Freedland KE, Saini J: Major depressive disorder predicts cardiac events in patients with coronary artery disease. Psychosom Med 1988; 50:627-633
4. Frasure-Smith N, Lesperance F, Talajic M: Depression following myocardial infarction: impact on 6-month survival. JAMA 1993; 270:1819-1861
5. Frasure-Smith N, Lesperance F, Talajic M: Depression and 18-month prognosis after myocardial infarction. Circulation 1995; 91:999-1005
6. Markovitz JH, Matthews KA: Platelets and coronary heart disease: potential psychophysiologic mechanism. Psychosom Med 1991; 53:643-668
7. Shattil SJ, Cunningham M, Hoxie JA: Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood 1987; 70:307-315
8. Report of the National Cholesterol Educational Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Arch Intern Med 1988; 148:36-69
9. Kestin AS, Ellis PA, Barnard MR, Errichetti A, Rosner BA, Michelson AD: Effect of strenuous exercise on platelet activation state and reactivity. Circulation 1993; 88:1502-1511
10. Goding JW: Monoclonal antibodies: principles and practice - production and application of monoclonal antibodies, in Cell Biology, Biochemistry and Immunology. London, Academic Press, 1986, pp 225-280
11. Shattil SJ, Hoxie JA, Cunningham MC, Brass LF: Changes in the platelet membrane glycoprotein IIb/IIIa complex during platelet activation. J Biol Chem 1985; 260:11107-11114
12. Scharf RE, Tomer A, Marzek UM, Teirstein PS, Ruggeri ZM, Harker LA: Activation of platelets in blood perfusing angioplasty-damaging coronary arteries: flow cytometric detection. Arterioscler Thromb 1992; 1475-1487
13. McEver RP, Martin MN: A monoclonal antibody to a membrane glycoprotein binds only to activated platelets. J Biol Chem 1984; 259:9799-9804
14. Tomer A, Eckman JR, Scharf RE, Harker LA: In vivo platelet receptor activation and membrane procoagulant activity determined by flow cytometry (abstract). Thromb Haemost 1993; 69: 967
15. Frelinger AL III, Cohen I, Plow EF, Smith MA, Roberts J, Lam SC, Ginsberg MH: Selective inhibition of integrin function by antibodies specific for ligand-occupied receptor conformers. J Biol Chem 1990; 265:6346-6352
16. Files JC, Malpass TW, Yee EK, Ritchie JL, Harker LA: Studies of human platelet alpha-granule release in vivo. Blood 1981; 58: 607-618
17. Kaplan KL, Owen J: Radioimmunoassays of platelet alpha-granule proteins, in Measurements of Platelet Function. Edited by Harker LA, Zimmerman TS. Edinburgh, Churchill Livingstone, 1983, pp 115-125
18. Colman RW, Walsh PN: Mechanism of platelet aggregation, in Hemostasis and Thrombosis: Basic Principles and Clinical Practice, 2nd ed. Edited by Colman RW, Hirsh J, Marder VJ, Salzman EW. Philadelphia, JB Lippincott, 1987, pp 594-605
19. Kinlough-Rathbone RL, Packham MA, Mustard JF: Platelet aggregation, in Measurements of Platelet Function. Edited by Harker LA, Zimmerman TS. Edinburgh, Churchill Livingstone, 1983, pp 64-91
20. Harker LA, Malpass TW, Branson HE, Hessel I, Slichter SJ: Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: acquired transient platelet dysfunction associated with selective alpha granule release. Blood 1980; 56:824-834
21. 2 receptor binding on blood platelets - a peripheral marker for depression? Life Sci 1987; 41:2485-2492
22. 3H-LSD in the blood platelets of depressed patients. Life Sci 1989; 44:725-734
23. Pandey GN, Pandey SC, Janicak PG: Platelet serotonin-2 binding sires in depression and suicide. Biol Psychiatry 1990; 28:215-222
24. 3H]imipramine binding sites in geriatric depression. Arch Gen Psychiatry 1988; 45:919-923
25. Nemeroff CB, Knight DL, Franks J, Craighead WE, Krishnan KRR: Further studies on platelet serotonin transporter binding in depression. Am J Psychiatry 1994; 151:1623-1625
26. 2-receptors and serotonin release: their role in human platelet aggregation. Life Sci 1993; 53:209-215